drugset / Trial / NCT05323149
Tranexamic Acid in Traumatic Brain Injury
RandomizedParallel-groupQuadruple-blindTreatment
Summary
In this study, our aim is to investigate the role of tranexamic acid for modulating the inflammation in patients with traumatic brain injury (TBI).
Timeline
- Start
- 2022-05-18
- Primary completion
- 2027-09-10
- Completion
- 2027-10-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tranexamic Acid | Small molecule | 1 g | — |